CD8+T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Papiris, Spyros A ^a   Kollintza, Androniki ^a   Karatza, Marilena ^b   Manali, Effrosyni D ^a   Sotiropoulou, Christina ^a   Milic Emili, Joseph ^c   Roussos, Charis ^a   Daniil, Zoe ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; CARBON DIOXIDE TENSION; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; DYSPNEA; EOSINOPHIL; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DIFFUSION; LUNG LAVAGE; MACROPHAGE; MALE; MEDICAL RESEARCH COUNCIL CHRONIC DYSPNEA SCALE; NEUTROPHIL; OXYGEN TENSION; PATHOGENESIS; RATING SCALE; RESIDUAL VOLUME; REVIEW; TOTAL LUNG CAPACITY;

EID: 34447103402     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-14     Document Type: Review

References (32)

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society, Am J Respir Crit Care Med 2002 161 646 664
2. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. SA Papiris ZD Daniil K Malagari G Kapotsis C Sotiropoulou J Milic-Emili Ch Roussos, Respir Med 2005 99 755 761 10.1016/j.rmed.2004.10.018 15878493
3. Fibrotic idiopathic interstitial pneumonia. The prognostic value of longitudinal functional trends. PI Latsi RM du Bois AG Nicholson TB Colby D Bisirtzoglou A Nikolakopoulou S Veeraghavan DM Hansell AU Wells, Am J Respir Crit Care Med 2003 168 531 537 10.1164/rccm.200210-1245OC 12791580
4. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. HR Collard TE King BB Bartelson JS Vourlekis MI Schwarz KK Brown, Am J Respir Crit Care Med 2003 168 538 542 10.1164/rccm.200211-1311OC 12773325
5. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications therapy. M Selman TE King Jr A Pardo, Ann Intern Med 2001 134 136 151 11177318
6. Prognostic role of eosinophils in pulmonary fibrosis. MW Peterson M Monick GW Hunninghake, Chest 1987 92 51 56 3595249
7. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. JP Lynch 3rd TJ Standiford MW Rolfe SL Kunkel RM Strieter, Am Rev Respir Dis 1992 145 1433 1439 1596015
8. BAL cell differentials in newly defined subgroups of idiopathic interstitial pneumonia. HM Mueller D Theegarten U Costabel, Eur Respir J 2001 18 Suppl 33 507s
9. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Z Daniil P Kitsanta G Kapotsis M Mathioudaki A Kollintza M Karatza J Milic Emili Ch Roussos S Papiris, Respiratory Research 2005 6 81 16042790 10.1186/1465-9921-6-81
10. Relationship of BAL and lung tissue CD4+ and CD+8 T lymphocytes and their ratio in idiopathic pulmonary fibrosis. SA Papiris A Kollintza P Kitsanta G Kapotsis M Karatza J Milic-Emili Ch Roussos Z Daniil, Chest 2005 128 2971 2977 10.1378/chest.128.4.2971 16236974
11. Bronchoalveolar lavage in interstitial lung disease. U Costabel J Guzman, Curr Opin Pulm Med 2001 7 255 261 10.1097/00063198-200109000-00002 11584173
12. Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis. H Groen M Hamstra R Aalbers TW van der Mark GH Koeter DS Postma, Respir Med 1994 88 55 64 10.1016/0954-6111(94)90175-9 8029515
13. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. E Fireman N Vardinon M Burke S Spizer S Levin A Endler D Stav M Topilsky A Mann Y Schwarz S Kivity J Greif, Eur Respir J 1998 11 706 711 9596125
14. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Thoracic Society/European Respiratory Society, Am J Respir Crit Care Med 2002 165 277 304 11790668
15. Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. PhH Quanjer GJ Tammeling JE Cotes OF Pedersen R Peslin J-C Yernault, Eur Respir J 1993 16 5 40
16. Standardization of the measurement of transfer factor (Diffusing Capacity). Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. JE Cotes DJ Chinn PhH Quanjer J Roca J-C Yernault, Eur Respir J 1993 16 41 52
17. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. L Eltayara MR Becklake CA Volta J Milic-Emili, Am J Respir Crit Care Med 1996 154 1726 1734 8970362
18. Improved immnunophenotyping of lymphocytes in bronchoalveolar lavage fluid (BALF) by flow cytometry. W Ma W Cui Q Lin, Clin Chim Acta 2001 313 133 8 10.1016/S0009-8981(01)00664-7 11694250
19. Idiopathic pulmonary fibrosis. TJ Gross GW Hunninghake, N Engl J Med 2001 345 517 25 10.1056/NEJMra003200 11519507
20. Histopathologic variability in usual and nonspecific interstitial pneumonias. KR Flaherty WD Travis TV Colby GB Toews EA Kazerooni BA Gross A Jain RL Strawderman A Flint JR Lynch FJ Martinez, Am J Respir Crit Care Med 2001 164 1722 1727 11719316
21. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. BAL cooperative Group Steering Committee, Am Rev Respir Dis 1990 141 S169 S202 2186681
22. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. ZD Daniil FC Gilchrist AG Nicholson DM Hansell J Harris TV Colby RM du Bois, Am J Respir Crit Care Med 1999 160 899 905 10471616
23. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. L Welker RA Jörres U Costabel H Magnussen, Eur Respir J 2004 24 1000 1006 10.1183/09031936.04.00101303 15572545
24. Usual interstitial pneumonitis is a T-cell alveolitis. RL Kradin MB Divertie RB Colvin J Ramirez J Ryu HA Carpenter AK Bhan, Clin Immunol Immunopathol 1986 40 224 235 10.1016/0090-1229(86)90025-5 3521973
25. Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses. SA Papiris PG Vlachoyiannopoulos MA Maniati KX Karakostas SH Constantopoulos HH Moutsopoulos, Respiration 1997 64 81 85 9044481
26. The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. MP Keane RM Strieter, Respir Res 2002 3 5 13 11806840 10.1186/rr177
27. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. SP Atamas VV Yurovsky R Wise FM Wigley CJ Goter Robinson P Henry WJ Alms B White, Arthritis Rheum 1999 42 1168 1178 10.1002/1529-0131(199906)42:6<1168::AID- ANR13>3.0.CO;2-L 10366109
28. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation. MQ Zhao MK Amir WR Rice RI Enelow, Am J Respir Cell Mol Biol 2001 25 362 369 11588015
29. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? A Savarino F Bottarel F Malavasi U Dianzani, AIDS 2000 14 1079 1089 10.1097/00002030-200006160-00004 10894271
30. Raised plasma concentrations of α-defensins in idiopathic pulmonary fibrosis. H Mukae H Iiboshi M Nakazato T Hiratsuka M Tokojima K Abe J Ashitani J Kadota S Matsukura S Kohno, Thorax 2002 57 623 628 10.1136/thorax.57.7.623 12096207
31. Comparison of alveolar septal inflammation to bronchoalveolar lavage in interstitial lung diseases. N Nagata K Takayama Y Nikaido Y Yokosaki M Kido, Respiration 1996 63 94 99 8966373
32. High short term mortality following lung biopsy for usual interstitial pneumonia. J Utz J Ryu W Douglas TE Hartman HD Tazelaar JL Myers MS Allen DD Schroeder, Eur Respir J 2001 17 175 179 10.1183/09031936.01.17201750 11334116